Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.81% is in line with its 5-year average of 0.82%, around the middle of its 5-year range (0.03%–2.01%).
As of the fiscal period ended Tuesday, June 30, 2026. 13.86% below its 12-month average of 0.94%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.81%.
DEBT TO ASSETS RATIO
0.81%
DEBT TO ASSETS RATIO AVG TTM
0.94%
DEBT TO ASSETS RATIO AVG 3Y
1.02%
DEBT TO ASSETS RATIO AVG 5Y
0.82%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-13.86%
CURRENT VS 3Y AVG
-20.72%
CURRENT VS 5Y AVG
-0.77%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 592 covered companies
CURRENT VS SECTOR MEDIAN
+711.48%
vs the sector median at left
Immunome, Inc.
Market Cap
$1.95B
Debt to Assets Ratio
0.81%
TTM Avg
0.94%
3Y Avg
1.02%
5Y Avg
0.82%
Market Cap
$1.94B
Debt to Assets Ratio
0.75%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.99B
Debt to Assets Ratio
0.15%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.99B
Debt to Assets Ratio
0.08%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.01B
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.02B
Debt to Assets Ratio
0.73%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.89B
Debt to Assets Ratio
0.04%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Immunome, Inc. (IMNM) | $1.95B | 0.81% | 0.94% | 1.02% | 0.82% |
| Azenta, Inc. (AZTA)vs › | $1.97B | 0.03% | N/A | N/A | N/A |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.94B | 0.75% | N/A | N/A | N/A |
| AxoGen, Inc. (AXGN)vs › | $1.98B | 0.07% | N/A | N/A | N/A |
| Mineralys Therapeutics, Inc. (MLYS)vs › | $1.99B | 0.15% | N/A | N/A | N/A |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $1.99B | 0.08% | N/A | N/A | N/A |
| Inspire Medical Systems, Inc. (INSP)vs › | $2.01B | 0.03% | N/A | N/A | N/A |
| BioCryst Pharmaceuticals, Inc. (BCRX)vs › | $2.02B | 0.73% | N/A | N/A | N/A |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | 0.04% | N/A | N/A | N/A |
| Alvotech (ALVO)vs › | $2.04B | 0.91% | N/A | N/A | N/A |
Debt/Assets
0.8%
Debt/Equity
0.01
Current Ratio
15.08
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.81% |
| 2026-03-31 | 0.60% |
| 2025-12-31 | 0.56% |
| 2025-09-30 | 1.34% |
| 2025-06-30 | 1.40% |
| 2025-03-31 | 1.39% |
| 2024-12-31 | 2.01% |
| 2024-09-30 | 1.06% |
| 2024-06-30 | 0.94% |
| 2024-03-31 | 0.51% |
| 2023-12-31 | 1.11% |
| 2023-09-30 | 0.40% |
| 2023-06-30 | 1.18% |
| 2023-03-31 | 0.49% |
| 2022-12-31 | 1.21% |
| 2022-09-30 | 0.60% |
| 2022-06-30 | 0.49% |
| 2022-03-31 | 0.44% |
| 2021-12-31 | 0.55% |
| 2021-09-30 | 0.03% |
| 2021-06-30 | 0.07% |
| 2021-03-31 | 1.36% |
| 2020-12-31 | 1.38% |
| 2020-09-30 | 5.51% |
| 2020-06-30 | 6.12% |
| 2019-12-31 | 11.15% |
